Possible new acute leukemia marker, treatment target identified
Monday, May 13, 2013 - 13:00
in Health & Medicine
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia). The findings suggest that this molecule is important in leukemia development and should be targeted by a drug that will inhibit it.